Heinrich Dreismann - 19 May 2023 Form 4 Insider Report for Talis Biomedical Corp

Role
Director
Signature
/s/ Gillian Green, Attorney-in-Fact for Heinrich Dreismann
Issuer symbol
TLIS on OTC
Transactions as of
19 May 2023
Net transactions value
$0
Form type
4
Filing time
23 May 2023, 08:33:54 UTC
Previous filing
03 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock option (right to buy) Award $0 +190,000 $0.000000 190,000 19 May 2023 Common Stock 190,000 $0.4600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest monthly over three years from the grant date.